| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Physical Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel
Correspondence: Address reprint requests to Noam Agmon, E-mail: agmon{at}fh.huji.ac.il.
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
![]() | (1) |
A kinetics involves a distribution of barrier heights, which makes it highly nonexponential.
A subsequent theoretical model by Agmon and Hopfield (1983b)
suggested that protein relaxation slows down geminate ligand rebinding, giving rise to nonexponential kinetics. In this approach, simple two-state kinetics was utilized for the ligand
![]() | (2) |
Despite the long time which has elapsed since these observations, it was thus far not possible to fit the full time and temperature dependence to any kinetic model (Frauenfelder et al., 2002
). In the usual chemical kinetic approach, one solves a set of coupled ordinary differential equations depicting the assumed reaction scheme. Due to the distributed kinetics and relaxation it was not possible to explain the data this way.
For example, the horse-MbCO data by Post et al. (1993)
, analyzed below, was previously treated in either of two ways. The first (Post et al., 1993
; Kleinert et al., 1998
) is an empirical superposition of three time-dependent functions: A distribution of barrier heights for the short time component, a stretched exponential for the intermediate times, and a hyperbolic function depicting bimolecular rebinding from solution for the longest times.
The second approach extended the model of Agmon and Hopfield (1983b)
by constructing a temperature-dependent potential for the protein coordinate (Agmon and Sastry, 1996
, 1997). Since ligand escape from the pocket (state B) was not accounted for, this approach allowed us to fit the data only up to intermediate times, when the ligand exits from the heme pocket. The purpose of the present work is to extend the model so that it includes also a state C, enabling one to analyze the data up to longer times. This extension is timely, because more knowledge has accumulated on the ligand migration path in recent years.
Molecular-dynamics simulations were successful in mapping ligand escape pathways through the protein matrix (Case and Karplus, 1979
; Elber and Karplus, 1990
). Some of these pathways involve the hydrophobic "xenon cavities" discovered by Tilton et al. (1984)
. Binding kinetics for different Mb mutants and under Xe pressures (Scott and Gibson, 1997
; Scott et al., 2001
; Tetreau et al., 2004
) suggest that the ligand may migrate to the Xe1 cavity on the proximal side (the opposite side of the porphyrin ring from which it has detached), possibly via the Xe4 cavity on the distal side. Indeed, recent cryogenic x-ray studies (Ostermann et al., 2000
; Chu et al., 2000
) have located the dissociated CO in these cavities. Most notable are pioneering time-resolved x-ray crystallography studies (
rajer et al., 2001
; Schotte et al., 2003
) that follow, in real time, the ligand rebinding, ligand migration, and structural changes in the protein.
Despite this progress, the actual exit point of the ligand to solution remains controversial. Many years ago, Perutz and Matthews (1966)
have suggested that the ligand escapes via the distal histidine (His-64) gate. This was observed in earlier molecular-dynamics simulations (Case and Karplus, 1979
), but later abandoned in favor of the multiple-pathway scenario (Elber and Karplus, 1990
). Today, some authors (Frauenfelder et al., 2002
) believe that the ligand escapes from the Xe1 cavity, in line with Eq. 1. In contrast, extensive mutagenesis work (Scott and Gibson, 1997
; Scott et al., 2001
) found a prominent effect on the rate constant for O2 entry when the distal histidine (His-64) was mutated, but little or no effect of mutations near the xenon cavities. The conclusion was therefore that the ligand exits/enters directly from state B.
Other authors (Tetreau et al., 2004
) suggest that the first scenario holds below 250 K, whereas the histidine gate becomes the dominant pathway near room temperature. Another possibility (Radding and Phillips, 2004
) is that the Xe cavity pathway is more important for CO than for O2, helping in discriminating against CO. The branched kinetic scheme sends the CO preferentially into the Xe1 cavity, functioning much like the Hopfield (1974)
proofreading mechanism.
The present work builds on the insight gained from such studies to construct a kinetic model that can explain quantitatively the laser photolysis data over wide time and temperature ranges. To avoid the exit pathway controversies, we focus on low temperature data (120250 K), where contributions from the solvent process are small. Since the x-ray data suggest that in wild-type Mb only the Xe1 cavity (and not Xe4) is appreciably populated, the kinetic scheme in Eq. 2 is extended by adding a single state, C. At higher temperatures and long times the migration path may be more complex, but the kinetics also becomes more closely exponential, thus containing less information to help unravel the kinetics.
The Agmon and Hopfield (1983b)
model is therefore extended into two coupled Smoluchowski equations, for the B and C states, respectively. As recently observed for other problems, such as single molecule enzymology (Agmon, 2000
) and diffusion-influenced reactions (Gopich and Szabo, 2002
), models based on two coupled Smoluchowski equations are already sufficiently powerful to reproduce a wide range of kinetic phenomena. With the extended approach presented below, it will be possible not only to fit, for the first time, all of the kinetic data by an equation of motion, but also to gain insight into the various stages of this fundamental biophysical process.
| THE MODEL |
|---|
|
|
|---|
|
The model outlined in Fig. 1 B captures these relaxation events qualitatively, although allowing for a quantitative computation of the rebinding kinetics. It is an extension of the Agmon and Hopfield (1983b)
model along similar lines used to describe the conformational cycle of a single working enzyme (Agmon, 2000
). The model involves three discrete ligand states, A, B, and C; A represents the bound Fe-CO state, B is the nascent photodissociated state, and C depicts the ligand in a more remote protein cavity, which in wild-type Mb appears to correspond to the Xe1 cavity (Chu et al., 2000
). In the time-resolved kinetics, B is the initial state whereas A serves as the final trap for the ligand.
The three states are coupled to a single conformational coordinate, denoted by x. It corresponds to the concerted motion of the iron center, the heme plane tilt and the distal pocket changes discussed above. Conformational changes are subject to effective harmonic potentials, e.g., VA(x) = aA(xxA)2, and similarly for the other two ligation states. (These potentials are given here in units of the thermal energy, kBT). The rate of conformational relaxation is determined by diffusive motion on these effective potentials. Because of the bounded potentials for the protein mode, such a model was termed by Agmon and Hopfield (1983b)
a "bounded diffusion" model.
As the ligand dissociates, the protein is out of equilibrium in the nascent B-state potential, VB(x). It relaxes to its new equilibrium value, xB. During this process, the iron out-of-plane motion and heme plane tilt make ligand rebinding less probable, so that the recombination rate coefficient, kBA(x), decreases. At the same time, distal relaxation (such as the tilt of His-64 and Leu-29) make the ligand escape out of the heme pocket more probable. Hence the escape rate coefficient, kBC(x), increases. After the expulsion of the ligand into state C, the distal pocket is again out of equilibrium in the new potential field, VC(x). It thus relaxes back, e.g., by reorienting His-64 and Leu-29 to block the return pathway and thus decrease the return rate coefficient, kCB(x). From the time-resolved crystallographic data, this reverse distal relaxation does not seem to couple to a corresponding reverse heme relaxation, yet both are depicted by the same coordinate in our model. To decouple the two motions on the long timescale, we allow for different "diffusion constants," DB and DC, for the B and C states, respectively. These determine the protein relaxation rates in these two states.
| METHODS |
|---|
|
|
|---|
![]() | (3) |
![]() | (4) |
produce diffusive relaxation in the two states,
= B or C. The rate functions coupling these partial differential equations describe ligand binding and migration,
![]() | (5) |
Initially, only state B is populated, and its conformational distribution is assumed identical to that which prevailed in state A before photodissociation,
![]() | (6) |
The total occupation of states A, B, and C is denoted by PA(t), PB(t), and PC(t), respectively. The latter two are given by the respective integrals over the conformational space,
![]() | (7) |
= B or C. Assuming that a single ligand resides within the protein, PA(t) + PB(t) + PC(t) = 1, whereas initially PB(0) = 1 and PA(0) = PC(0) = 0. The survival probability of the unbound protein, S(t), is thus
![]() | (8) |
We note that the above equations may be extended to include ligand exchange with solution (state S). Escape to solution from state B (Scott et al., 2001
) will add a term kBS(x) pB(x, t) to Eq. 3. Similarly, if ligand escape occurs from state C (Frauenfelder et al., 2002
), a term kCS(x) pC(x, t) can be added to Eq. 4. CO entry through the distal histidine can be treated approximately by adding the term kSB(x)[CO] [1 PB(t)] to Eq. 3 (and similarly if entry is to state C). Here [CO] is the CO concentration in solution (which, unfortunately, is seldom determined in a quantitative manner). The term 1 PB(t) accounts for saturation of the distal pocket by preventing the entry of more than one ligand.
Present experimental data does not contain sufficient information to determine these additional parameters. Therefore we focus on analyzing the low temperature data (250 K and below), where the solvent process may be either less prominent or nonexistent.
| RESULTS |
|---|
|
|
|---|
Fig. 2 shows a fit of the complete temporal behavior to the solution of the bounded diffusion model described above. The parameters used in the fits are collected in Table 1. To reduce the number of adjustable parameters, some of them were held fixed over the whole temperature range. For example, the exponent b in the rate functions of the expressions in Eq. 5 was assigned a universal (positive) value. The parabolic potentials were assumed to be identical for the A- and C-states, hence aA = aC and xA = xC. Thus we adjust only aA/aB and xAxB (fixing aB and xB). We find that aB >> aA , which may be understood if the CO ligand docked in state B limits the fluctuations of the heme plane adjacent to it.
|
|
200 K (roughly the solvent glass transition, Tg), and diminishes above this temperature, "collapsing" nearly to zero as room temperature is approached. This operates to slow down the short-time rebinding kinetics above 200 K (the "inverse temperature effect"), in agreement with earlier work (Agmon and Sastry, 1996
In contrast to xA, DB appears to be insensitive to Tg, as it follows a simple Arrhenius behavior (Fig. 3), with ln DB being linear in 1/T over the whole temperature range (120280 K). From the slope, one obtains an activation energy of 31.5 kJ/mol. The linearity of this plot suggests that the relaxation of the heme plane is insensitive to the dynamics in the external solvent (Agmon and Sastry, 1996
). Considering the relaxation in the C-state, DC is indeed smaller than DB (except near room temperature, but there the fitting procedure may be nonunique), possibly showing an abrupt change around Tg. We conclude that 1), the distal pocket relaxation after ligand escape is slower than the heme relaxation after the photolysis event and 2), unlike the heme relaxation which is largely decoupled from the external solvent, the distal pocket relaxation is much more sensitive to the solvent.
|
Fig. 4 shows the two distributions, pB(x, t) and pC(x, t), and the sum of their areas, S(t), which is compared to the experimental kinetics at 220 K. The initial phase is due to static inhomogeneity, with more reactive conformations (for x << 0) rebinding first and disappearing from the ensemble. This "kinetic-hole burning" effect (KHB, Campbell et al., 1987
; Agmon, 1988
) gives rise to an initial power-law phase in S(t). It prevails until protein relaxation commences (
5 µs), and pB(x, t) moves out of its initial profile, pB(x, 0). This slows down the B
A rebinding, giving rise to the first undulation in S(t). Because aA << aB, pB(x, t) also narrows appreciably during this relaxation phase. When the B-state relaxation ends (
600 µs), pB(x, t) centers around xB and continues to decay only in amplitude.
|
C migration commences, and we observe an increase in the amplitude of the C-state distribution, pC(x, t). As a result, the rebinding kinetics slows down. Subsequent protein relaxation in state C moves pC(x, t) back to the left, from which the return rate is slower. The rebinding kinetics slows down even further, leading to the second undulation in S(t). At the termination of this second relaxation phase the kinetics tend to an ultimate exponential decay.
Ligand excursion to the Xe cavities
The kinetics of the CO excursion into state C (which we identify predominantly with Xe1) is depicted by the spatial integral over the C-state conformational manifold (see Eq. 7). As an example, Fig. 5 shows both pC(x, t) and PC(t) at 250 K. The population of state C (bottom panel) peaks
3 x 104 s and disappears by 3 x 102 s. It has a long tail into short times.
|
One also notes (in the bottom panel of their Fig. 5) that the effect of Xe pressure on O2 binding is much smaller than on CO binding. This agrees with the assessment of Radding and Phillips (2004)
, that migration into the Xe cavities is more prominent for CO (their estimated kBC is five-times larger for CO as compared with O2).
| CONCLUSION |
|---|
|
|
|---|
Firstly, the relaxation in both the B and C states operates to reduce the probability of geminate CO rebinding, and enhance the probability of its escape from the immediate vicinity of the heme iron. Whereas the nonexponential slowing-down of ligand rebinding is due to both protein relaxation and ligand migration, relaxation is more effective in slowing down the rebinding than ligand escape. It leads to the cascade-like time dependence of the survival probability (Fig. 2), with two conspicuous "steps" corresponding to the two relaxation processes. The complete sequence of events influencing the progress of geminate rebinding, as emerging from our analysis, is: inhomogeneous kinetics (kinetic-hole burning); B-relaxation; BC-escape; C-relaxation; and finally return from the cavity to state B (see bottom panel of Fig. 4, this article).
The second characteristic of protein relaxation is that it operates in a cyclic manner, relaxing in one direction in the B state and the opposite direction in the C state. In the photodissociation experiment, it operates like a microscopic cyclic engine, utilizing the photolyzing energy to move the ligand away from the heme, and dumping the remainder into the heat bath of all other protein modes.
When Agmon and Hopfield (1983b)
first put forward the idea that protein relaxation participates in the binding kinetics, the scenario could have been criticized based on the relatively small structural differences between MbCO and deoxy-Mb observed in the steady-state x-ray diffraction data. Time-resolved x-ray measurements (Schotte et al., 2003
) now reveal that the transient structural changes are actually much larger, but they occur in a cyclical manner so that their accumulated effect is rather small. The present model not only describes the laser photolysis kinetics quantitatively, but also produces this cyclic conformational change.
An important question concerns the biological significance of a mechanism which utilizes both cavities and protein conformations, particularly if the O2 ligand enters mainly through the histidine gate (Scott et al., 2001
). A possible conjecture is that Mb acts to preferentially move CO into the Xe cavities (Radding and Phillips, 2004
). If so, the conformational cycle may be instrumental in facilitating this outcome.
For ligands such as NO, Mb may function also as an enzyme (Frauenfelder et al., 2001
), catalyzing the reaction
(Eich et al., 1996
; Møller and Skibsted, 2002
). This reaction may be important in regulating NO levels in the brain or in the heart (Garry et al., 2003
). If NO is also preferentially channeled into the Xe1 cavity like CO, one may envision protein relaxation delaying its return for sufficiently long times, allowing for concomitant O2 binding to the heme iron. As the NO subsequently returns to state B, it collides with the iron-bound oxygen, leading to its rapid oxidation.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Submitted on March 16, 2004; accepted for publication May 26, 2004.
| REFERENCES |
|---|
|
|
|---|
Agmon, N. 2000. Conformational cycle of a single working enzyme. J. Phys. Chem. B. 104:78307834.
Agmon, N., W. Doster, and F. Post. 1994. The transition from inhomogeneous to homogeneous kinetics in CO binding to myoglobin. Biophys. J. 66:16121622.
Agmon, N., and J. J. Hopfield 1983a. Transient kinetics of chemical reactions with bounded diffusion perpendicular to the reaction coordinate: intramolecular processes with slow conformational changes. J. Chem. Phys. 78:69476959. Erratum, ibid. 1984. 80:592.[CrossRef]
Agmon, N., and J. J. Hopfield. 1983b. CO binding to heme proteins: a model for barrier height distributions and slow conformational changes. J. Chem. Phys. 79:20422053.[CrossRef]
Agmon, N., and G. M. Sastry. 1996. A temperature-dependent effective potential explains CO binding to myoglobin. Chem. Phys. 212:207219.[CrossRef]
Ansari, A., C. M. Jones, E. R. Henry, J. Hofrichter, and W. A. Eaton. 1992. The role of solvent viscosity in the dynamics of protein conformational change. Science. 256:17961798.
Ansari, A., C. M. Jones, E. R. Henry, J. Hofrichter, and W. A. Eaton. 1994. Conformational relaxation and ligand binding in myoglobin. Biochemistry. 33:51285145.[CrossRef][Medline]
Austin, R. H., K. W. Beeson, L. Eisenstein, H. Frauenfelder, and I. C. Gunsalus. 1975. Dynamics of ligand binding to myoglobin. Biochemistry. 14:53555373.[CrossRef][Medline]
Campbell, B. F., M. R. Chance, and J. M. Friedman. 1987. Linkage of functional and structural heterogeneity in proteins: dynamic hole burning in carboxymyoglobin. Science. 238:373376.
Case, D. A., and M. Karplus. 1979. Dynamics of ligand binding to heme proteins. J. Mol. Biol. 132:343368.[CrossRef][Medline]
Chu, K., J. Vojtchovsk
, B. H. McMahon, R. M. Sweet, J. Berendzen, and I. Schlichting. 2000. Structure of a ligand-binding intermediate in wild-type carbonmonoxy myoglobin. Nature. 403:921923.[CrossRef][Medline]
Eich, R. F., T. Li, D. D. Lemon, D. H. Doherty, S. R. Curry, J. F. Aitken, A. J. Matthews, K. A. Johnson, R. D. Smith, G. N. Phillips, Jr., and J. S. Olson. 1996. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 35:69766983.[CrossRef][Medline]
Elber, R., and M. Karplus. 1990. Enhanced sampling in molecular dynamics: use of the time-dependent Hartree approximation for a simulation of carbon monoxide diffusion through myoglobin. J. Am. Chem. Soc. 112:91619175.[CrossRef]
Frauenfelder, H., P. W. Fenimore, and B. H. McMahon. 2002. Hydration, slaving and protein function. Biophys. Chem. 98:3548.[CrossRef][Medline]
Frauenfelder, H., B. H. McMahon, R. H. Austin, K. Chu, and J. T. Groves. 2001. The role of structure, energy landscape, dynamics, and allostery in the enzymatic function of myoglobin. Proc. Natl. Acad. Sci. USA. 98:23702374.
Garry, D. J., S. B. Kanatous, and P. P. A. Mammen. 2003. Emerging roles for myoglobin in the heart. Trends Cardiovasc. Med. 13:111116.[CrossRef][Medline]
Gopich, I. V., and A. Szabo. 2002. Kinetics of reversible diffusion influenced reactions: the self-consistent relaxation time approximation. J. Chem. Phys. 117:507517.[CrossRef]
Hopfield, J. J. 1974. Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity. Proc. Natl. Acad. Sci. USA. 71:41354139.
Kachalova, G. S., A. N. Popov, and H. D. Bartunik. 1999. A steric mechanism for inhibition of CO binding to heme proteins. Science. 284:473476.
Kleinert, T., W. Doster, H. Leyser, W. Petry, V. Schwarz, and M. Settles. 1998. Solvent composition and viscosity effects on the kinetics of CO binding to horse myoglobin. Biochemistry. 37:717733.[CrossRef][Medline]
Krissinel', E. B., and N. Agmon. 1996. Spherical symmetric diffusion problem. J. Comput. Chem. 17:10851098.[CrossRef]
Lim, M., T. A. Jackson, and P. A. Anfinrud. 1993. Nonexponential protein relaxation: dynamics of conformational change in myoglobin. Proc. Natl. Acad. Sci. USA. 90:58015804.
Møller, J. K. S., and L. H. Skibsted. 2002. Nitric oxide and myoglobins. Chem. Rev. 102:11671178.[CrossRef][Medline]
Ostermann, A., R. Waschipky, F. G. Parak, and G. U. Nienhaus. 2000. Ligand binding and conformational motions in myoglobin. Nature. 404:205208.[CrossRef][Medline]
Perutz, M. F., and F. S. Matthews. 1966. An x-ray study of azide methaemoglobin. J. Mol. Biol. 21:199202.[CrossRef][Medline]
Petrich, J. W., J.-C. Lambry, K. Kuczera, M. Karplus, C. Poyart, and J.-L. Martin. 1991. Ligand binding and protein relaxation in heme proteins: a room temperature analysis of NO geminate recombination. Biochemistry. 30:39753987.[CrossRef][Medline]
Post, F., W. Doster, G. Karvounis, and M. Settles. 1993. Structural relaxation and nonexponential kinetics of CO-binding to horse myoglobin: multiple flash photolysis experiments. Biophys. J. 64:18331842.
Radding, W., and G. N. Phillips, Jr. 2004. Kinetic proofreading by the cavity system of myoglobin: protection from poisoning. Bioessays. 26:422433.[CrossRef][Medline]
Sastry, G. M., and N. Agmon. 1997. Trehalose prevents protein collapse and preserves its internal mobility. Biochemistry. 36:70977108.[CrossRef][Medline]
Schotte, F., M. Lim, T. A. Jackson, A. V. Smirnov, J. Soman, J. S. Olson, G. N. Phillips, Jr., M. Wulff, and P. A. Anfinrud. 2003. Watching a protein as it functions with 150-ps time-resolved x-ray crystallography. Science. 300:19441947.
Scott, E. E., and Q. H. Gibson. 1997. Ligand migration in sperm whale myoglobin. Biochemistry. 36:1190911917.[CrossRef][Medline]
Scott, E. E., Q. H. Gibson, and J. S. Olson. 2001. Mapping the pathways for O2 entry into and exit from myoglobin. J. Biol. Chem. 276:51775188.
rajer, V., Z. Ren, T.-Y. Teng, M. Schmidt, T. Ursby, D. Bourgeois, C. Pradervand, W. Schildkamp, M. Wulff, and K. Moffat. 2001. Protein conformational relaxation and ligand migration in myoglobin: a nanosecond to millisecond molecular movie from time-resolved Laue x-ray diffraction. Biochemistry. 40:1380213815.[CrossRef][Medline]
Steinbach, P. J., A. Ansari, J. Berendzen, D. Braunstein, K. Chu, B. R. Cowen, D. Ehrenstein, H. Frauenfelder, J. B. Johnson, D. C. Lamb, S. Luck, J. R. Mourant, G. U. Nienhaus, P. Ormos, R. Philipp, A. Xie, and R. D. Young. 1991. Ligand binding to heme proteins: connection between dynamics and function. Biochemistry. 30:39884001.[CrossRef][Medline]
Tetreau, C., Y. Blouquit, E. Novikov, E. Quiniou, and D. Lavalette. 2004. Competition with xenon elicits ligand migration and escape pathways in myoglobin. Biophys. J. 86:435447.
Tian, W. D., J. T. Sage, V.
rajer, and P. M. Champion. 1992. Relaxation dynamics of myoglobin in solution. Phys. Rev. Lett. 68:408411.[CrossRef][Medline]
Tilton, R. F., Jr., I. D. Kuntz, Jr., and G. A. Petsko. 1984. Cavities in proteins: structure of a metmyoglobin-xenon complex solved to 1.9 Å resolution. Biochemistry. 23:28492857.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
M. Ceccarelli, P. Ruggerone, R. Anedda, A. Fais, B. Era, M. C. Sollaino, M. Corda, and M. Casu Structure-Function Relationship in a Variant Hemoglobin: A Combined Computational-Experimental Approach Biophys. J., November 1, 2006; 91(9): 3529 - 3541. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Nutt and M. Meuwly Studying Reactive Processes with Classical Dynamics: Rebinding Dynamics in MbNO Biophys. J., February 15, 2006; 90(4): 1191 - 1201. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |